Leslie Trigg

Chief Executive Officer
Outset Medical

Leslie Trigg was previously Outset’s chief operating officer and an executive-in-residence at Warburg Pincus. Prior to Outset, she was executive vice president at Lutonix, a cardiovascular medical device company acquired by CR Bard. Prior to Lutonix, Leslie served as chief business officer of AccessClosure, a vascular closure company acquired by Cardinal Health. Before joining AccessClosure, she was the vice president, marketing for FoxHollow Technologies, helping to architect the strategy and commercial infrastructure that led to a successful IPO and subsequent acquisition by ev3/Covidien. Trigg’s management experience also includes senior leadership positions at Cytyc Corporation and breast cancer diagnostics company, Pro-Duct Health, Inc., which was acquired by Cytyc. She began her medical device career at Guidant Corporation in new product global marketing. Trigg is currently a board member of Cardiovascular Systems, Inc. (NASDAQ: CSII).

She received her undergraduate degree from Northwestern University and her Master of Business Administration degree from the Haas School of Business, UC Berkeley.